Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Biological Psychiatry,Psychiatry and Mental health,General Medicine
Reference124 articles.
1. Abi-Dargham A (2004) Do we still believe in the dopamine hypothesis? New data bring new evidence. Int J Neuropsychopharmacol 7(Suppl 1):S1–S5
2. Akiskal H (2005) The bipolar spectrum: history, description, boundaries, and validity. In: Kasper S, Hirschfeld RMA (eds) Handbook of bipolar disorder. Taylor & Francis, Abingdon, Oxford, London pp 49–68
3. Akiskal H (2007) The interface of affective and schizophrenic disorders: a cross between two spectra? In: Marneros A, Akiskal H (eds) The overlap of affective and schizophrenic spectra. Cambridge University Press, Cambridge, pp 277–291
4. Akiskal HS (1999) Bipolar disorder: outcome. New Engl J Med 341:1861–1862
5. Akiskal HS (2002) The bipolar spectrum–the shaping of a new paradigm in psychiatry. Curr Psychiatry Rep 4:1–3
Cited by
20 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Classification Systems of Mental Disorders: Where Did We Go Wrong?;New Directions in Psychiatry;2020
2. Modern classification and clinical psychiatry;Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova;2015
3. DSM-5 reviewed from different angles: goal attainment, rationality, use of evidence, consequences—part 2: bipolar disorders, schizophrenia spectrum disorders, anxiety disorders, obsessive–compulsive disorders, trauma- and stressor-related disorders, personality disorders, substance-related and addictive disorders, neurocognitive disorders;European Archives of Psychiatry and Clinical Neuroscience;2014-08-26
4. DSM-5 reviewed from different angles: goal attainment, rationality, use of evidence, consequences—part 1: general aspects and paradigmatic discussion of depressive disorders;European Archives of Psychiatry and Clinical Neuroscience;2014-08-14
5. The consequences of DSM-5 for psychiatric diagnosis and psychopharmacotherapy;International Journal of Psychiatry in Clinical Practice;2014-02-04